rituximab-pvvr
| Brand name | Ruxience |
|---|---|
| Active ingredient | rituximab-pvvr |
| Strength | 100MG/10ML (10MG/ML) |
| Dosage form | Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | July 2019 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.